Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amicus Therapeutics (FOLD) Restructuring Costs (2016 - 2024)

Historic Restructuring Costs for Amicus Therapeutics (FOLD) over the last 7 years, with Q3 2024 value amounting to $3.1 million.

  • Amicus Therapeutics' Restructuring Costs changed N/A to $3.1 million in Q3 2024 from the same period last year, while for Jun 2025 it was $3.1 million, marking a year-over-year decrease of 4800.66%. This contributed to the annual value of $9.2 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Amicus Therapeutics reported Restructuring Costs of $3.1 million as of Q3 2024.
  • Amicus Therapeutics' Restructuring Costs' 5-year high stood at $6.0 million during Q1 2024, with a 5-year trough of $3.1 million in Q3 2024.